{"id":25475,"date":"2022-06-24T13:24:18","date_gmt":"2022-06-24T12:24:18","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=25475"},"modified":"2022-06-24T13:24:22","modified_gmt":"2022-06-24T12:24:22","slug":"biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/","title":{"rendered":"Biomarker &#038; Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022"},"content":{"rendered":"\n<p><a href=\"https:\/\/muse.edu.umontpellier.fr\/key-initiatives-muse\/biomarkers-therapy\/\" target=\"_blank\" rel=\"noreferrer noopener\">La Key Initiative Biomarkers &amp; Therapy de l\u2019I-SITE MUSE<\/a>,<a href=\"https:\/\/www.agence-adocc.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00a0l\u2019Agence R\u00e9gionale AD\u2019OCC<\/a>\u00a0et le<a href=\"https:\/\/www.eurobiomed.org\/fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00a0P\u00f4le de comp\u00e9titivit\u00e9 Eurobiomed<\/a>\u00a0organisent la 6\u00e8me \u00e9dition des <a href=\"https:\/\/muse.edu.umontpellier.fr\/2022\/02\/01\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-le-microbiote-une-filiere-diagnostic-qui-evolue-28-29-juin-2022\/#\" target=\"_blank\" rel=\"noreferrer noopener\">Biomarker &amp; Therapy Days<\/a>, qui se d\u00e9roulera \u00e0 la\u00a0<strong>nouvelle Facult\u00e9 de M\u00e9decine de Montpellier<\/strong>\u00a0les<strong>\u00a028 et 29 juin 2022.28 juin : Le microbiote, un outil d\u2019avenir<\/strong><\/p>\n\n\n\n<ul><li>Keynote<\/li><li>Session Biomarqueurs &amp; Diagnostic<\/li><li>Outils technologiques<\/li><li>Session Th\u00e9rapie<\/li><li>Outils biotechnologiques<\/li><li>Viewpoint (conf\u00e9rencier international)<\/li><li>Table ronde<\/li><\/ul>\n\n\n\n<p><strong>29 juin : Le diagnostic au plus pr\u00e8s du patient<\/strong><\/p>\n\n\n\n<ul><li>Success story r\u00e9gionale<\/li><li>Evolutions et enjeux technologiques des tests diagnotic pour plus d\u2019innovation, de d\u00e9centralisation et de pr\u00e9vention<\/li><li>Quel environnement pour soutenir cette dynamique ?<\/li><\/ul>\n\n\n\n<p>T\u00e9l\u00e9charger <a href=\"https:\/\/muse.edu.umontpellier.fr\/files\/2022\/02\/Programme-Biomarkers-Therapy-days-2022-17.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">le programme<\/a><\/p>\n\n\n\n<p>S&#8217;inscrire <a href=\"https:\/\/www.alphavisa.com\/biomarkerdays\/2022\/index.php\" target=\"_blank\" rel=\"noreferrer noopener\">sur cette page web<\/a><\/p>\n\n\n\n<p>T\u00e9l\u00e9charger le <a href=\"https:\/\/muse.edu.umontpellier.fr\/files\/2022\/02\/LIVRET-BMK-THERAPY-DAYS-2022-1.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">livret de l&#8217;\u00e9v\u00e8nement<\/a><\/p>\n\n\n\n<p><strong>Contacts <\/strong><\/p>\n\n\n\n<p>KIM \u00ab\u00a0Biomarkers &amp; Therapy\u00a0\u00bb :\u00a0<a href=\"mailto:brigitte.couette@umontpellier.fr\" target=\"_blank\" rel=\"noreferrer noopener\">Brigitte Couette<\/a><br>Agence R\u00e9gionale AD\u2019OCC :\u00a0<a href=\"mailto:marjorie.monleau@agence-adocc.com\" target=\"_blank\" rel=\"noreferrer noopener\">Marjorie Monleau<\/a><br>P\u00f4le de comp\u00e9titivit\u00e9 Eurobiomed :\u00a0<a href=\"mailto:laurent.garnier@eurobiomed.org\" target=\"_blank\" rel=\"noreferrer noopener\">Laurent Garnier<\/a><\/p>\n\n\n\n<p>\u200b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Key Initiative Biomarkers &amp; Therapy de l\u2019I-SITE MUSE,\u00a0l\u2019Agence R\u00e9gionale AD\u2019OCC\u00a0et le\u00a0P\u00f4le de comp\u00e9titivit\u00e9 Eurobiomed\u00a0organisent la 6\u00e8me \u00e9dition des Biomarker &amp; Therapy Days, qui se d\u00e9roulera \u00e0 la\u00a0nouvelle Facult\u00e9 de M\u00e9decine de Montpellier\u00a0les\u00a028 et 29 juin 2022.28 juin : Le microbiote, un outil d\u2019avenir Keynote Session Biomarqueurs &amp; Diagnostic Outils technologiques Session Th\u00e9rapie Outils biotechnologiques [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":25497,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[35],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biomarker &amp; Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomarker &amp; Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-24T12:24:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-24T12:24:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"774\" \/>\n\t<meta property=\"og:image:height\" content=\"581\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Biomarker &#038; Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022\",\"datePublished\":\"2022-06-24T12:24:18+00:00\",\"dateModified\":\"2022-06-24T12:24:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\"},\"wordCount\":177,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg\",\"articleSection\":[\"Ev\u00e8nements &amp; Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\",\"name\":\"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg\",\"datePublished\":\"2022-06-24T12:24:18+00:00\",\"dateModified\":\"2022-06-24T12:24:22+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg\",\"width\":774,\"height\":581,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ev\u00e8nements &amp; Colloques\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/","og_locale":"fr_FR","og_type":"article","og_title":"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2022-06-24T12:24:18+00:00","article_modified_time":"2022-06-24T12:24:22+00:00","og_image":[{"width":774,"height":581,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Biomarker &#038; Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022","datePublished":"2022-06-24T12:24:18+00:00","dateModified":"2022-06-24T12:24:22+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/"},"wordCount":177,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg","articleSection":["Ev\u00e8nements &amp; Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/","name":"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022 - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg","datePublished":"2022-06-24T12:24:18+00:00","dateModified":"2022-06-24T12:24:22+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/06\/ADN-Torsade.jpg","width":774,"height":581,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/biomarker-therapy-days-ce-qui-se-profile-dici-2030-en-termes-de-diagnostic-et-de-therapie-nouvelle-faculte-de-medecine-de-montpellier-28-et-29-juin-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Ev\u00e8nements &amp; Colloques","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/"},{"@type":"ListItem","position":4,"name":"Biomarker & Therapy Days \u00ab Ce qui se profile d\u2019ici 2030 en termes de diagnostic et de th\u00e9rapie \u00bb, Nouvelle facult\u00e9 de m\u00e9decine de Montpellier, 28 et 29 juin 2022"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 14:23:16","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/25475"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=25475"}],"version-history":[{"count":13,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/25475\/revisions"}],"predecessor-version":[{"id":25521,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/25475\/revisions\/25521"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/25497"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=25475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=25475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=25475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}